James E. Shmerling - 12 May 2022 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
Director
Signature
/s/ Chad Porter, by power of attorney
Issuer symbol
BSTG
Transactions as of
12 May 2022
Transactions value $
$100,001
Form type
4
Filing time
23 May 2022, 14:46:44 UTC
Previous filing
10 Nov 2021
Next filing
01 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSTG Common Stock Purchase $100,000 +16,892 $5.92 16,892 12 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Warrants (right to buy) Purchase +8,446 8,446 12 May 2022 Common Stock 8,446 $8.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 16,892 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 8,446 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $100,000.

Remarks:

This form has been signed under power of attorney.